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Abstract
Background: Chronic obstructive pulmonary disease (COPD) guidelines recommend early access to palliative care
together with optimal, disease-directed therapy for people with advanced disease, however, this occurs
infrequently. This study explored the approaches of respiratory and palliative medicine specialists to palliative care
and advance care planning (ACP) in advanced COPD.
Methods: An online survey was emailed to all specialists and trainees in respiratory medicine in Australia and New
Zealand (ANZ), and to all palliative medicine specialists and trainees in ANZ and the United Kingdom.
Results: Five hundred seventy-seven (33.1%) responses were received, with 440 (25.2%) complete questionnaires
included from 177 respiratory and 263 palliative medicine doctors. Most respiratory doctors (140, 80.9%) were very
or quite comfortable providing a palliative approach themselves to people with COPD. 113 (63.8%) respiratory
doctors recommended referring people with advanced COPD to specialist palliative care, mainly for access to:
psychosocial and spiritual care (105, 59.3%), carer support (104, 58.5%), and end-of-life care (94, 53.1%). 432 (98.2%)
participants recommended initiating ACP discussions. Palliative medicine doctors were more likely to recommend
discussing: what palliative care is (p < 0.0001), what death and dying might be like (p < 0.0001) and prognosis (p =
0.004). Themes highlighted in open responses included: inadequate, fragmented models of care, with limited
collaboration or support from palliative care services.
Conclusions: While both specialties recognised the significant palliative care and ACP needs of people with
advanced COPD, in reality few patients access these elements of care. Formal collaboration and bi-directional
support between respiratory and palliative medicine, are required to address these unmet needs.
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Background
Chronic obstructive pulmonary disease (COPD) is char-
acterised by airflow limitation, persistent symptoms and
respiratory failure [1]. By 2020, COPD is projected to be
the third leading cause of death worldwide [2]. Yet des-
pite many people expressing a desire to die at home,
seven out of ten people with COPD die in hospital in
Australia and the United Kingdom (UK) [3, 4].
Many patients with severe COPD experience reduced
quality of life due to severe, chronic breathlessness, which
persists at rest or on minimal exertion despite optimal treat-
ment of the underlying causes [5–7]. Disease progression is
also reflected in reduced function, limiting basic activities of
daily living and requiring additional support from informal
and paid caregivers, often for long periods of time [8]. In
addition to other physical symptoms such as cough, pain,
anorexia and fatigue, many patients have significant psycho-
logical comorbidity, with all these factors contributing to
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reduced quality of life and increasing social isolation for
both patients and caregivers [9, 10].
Given the significant physical, psychosocial and com-
munication needs of people with COPD [11], guidelines
recommend that patients with advanced disease should
receive early access to palliative care in conjunction with
optimal, disease-directed therapy [1, 12]. Therefore all
health professionals have a role in providing palliative
care to their patients [12]. Indeed when palliative care is
provided by the usual treating clinician (such as the gen-
eral practitioner or a medical specialist), it is termed gen-
eralist palliative care or a palliative approach [13]. By
contrast, specialist palliative care is provided by health
professionals who have specialist qualifications and/or
significant experience in palliative care. Specialist pallia-
tive care teams not only support the usual treating clin-
ician to offer a palliative approach, but have an
important role in caring for people with challenging
symptoms or complex needs [12]. Thus a palliative ap-
proach and specialist palliative care are not separate en-
tities, but may be complementary aspects of care for
patients with advanced COPD.
Despite guidelines recommending palliative care for
people with advanced COPD, referral to specialist pallia-
tive care service occurs infrequently [14–16]. Only 1.7%
of patients with end-stage COPD in the USA were re-
ferred to specialist palliative care when admitted with an
exacerbation [16]. Similarly, in the UK and Australia
only 16.7–17.9% of COPD patients accessed any special-
ist palliative care in their last year of life [15, 17, 18]. Yet
people with severe COPD have documented needs
which are similar to those of people at the end-of-life, ir-
respective of the underlying life-limiting illness [19]. Ad-
vance care planning (ACP), which by definition should
include discussion of each patient’s palliative care
wishes, also seldom occurs in routine practice [20–22].
Well-described barriers to accessing palliative care in-
clude difficulty prognosticating in COPD due to the vari-
able disease trajectory [23, 24], clinicians lacking time to
discuss palliative care or being fearful of taking away
hope [25], and availability of specialist palliative care
from services which are already overburdened [26, 27].
Given these issues, a survey was undertaken to explore
physicians’ knowledge and practices managing people
with advanced COPD. This manuscript reports current
beliefs and practices of respiratory and palliative medi-
cine doctors regarding the role of specialist palliative
care and advance care planning in patients with severe
COPD.
Methods
The full methodology including the research question-
naire utilised for this study have been published else-
where [28], therefore the methods are summarised here.
A voluntary survey was designed for specialists and spe-
cialist trainees working in respiratory medicine in
Australia and New Zealand (ANZ) and palliative medi-
cine in ANZ and the United Kingdom (UK). The ques-
tionnaire included a case vignette describing an
outpatient with severe COPD, receiving maximum dis-
ease modifying therapies and worsening, severe chronic
breathlessness (modified Medical Research Council
breathlessness score of 4). Survey participants were told
the case patient did not have anxiety and was not in the
terminal phase (last few days) of his illness. Respondents
were asked to consider how they would manage the case
patient or people with COPD similar to the case. All sur-
vey questions (including demographic information at the
start of the survey) required an answer, before the re-
spondent could proceed to the next question.
The link to the online survey (written in Survey Mon-
key) was distributed by the Thoracic Society of Australia
and New Zealand, the Australian and New Zealand Soci-
ety of Palliative Medicine, and the Association for Pallia-
tive Medicine of Great Britain and Ireland to their
members. Each society member received two email invi-
tations including the survey link, 2–4 weeks apart. The
online survey was open to participants for six months
from August 2015 to February 2016, with participants
only able to submit one response from their IP address.
Consent to participate was implied by completion of the
survey questionnaire. Ethics approval was granted by the
Melbourne Health Research Office (QA2014171). Separ-
ate ethics approvals from each specialist society were
not required. Similarly health professional research stud-
ies that did not collect sensitive data, did not require
ethics approval in the UK in 2015 [29].
Statistical analysis
Demographic data and responses are reported descrip-
tively using frequencies and proportions. The Pearson
Chi-Square test was used to identify associations be-
tween participants’ responses and exposure variables
measured as proportions (age, gender, country, specialty,
position and location of practice); and Student’s t test
was used for exposures measured as continuous numer-
ical values (mean years worked in specialty and mean
number of patients with severe COPD seen per month).
Statistical analyses were performed using IBM SPSS Sta-
tistics Version 24.0, with a p-value of less than 0.05 indi-
cating statistical significance. Free text responses to
open ended questions were analysed using thematic
analysis.
Results
Five hundred and seventy-seven (33.0%) responses were
received from 1047 doctors working in palliative medi-
cine (323 in ANZ and 724 in the UK) and 702 working
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in respiratory medicine who were emailed the survey
link. Responses were excluded from participants who:
provided incomplete responses regarding patient man-
agement (94), were not respiratory or palliative medicine
doctors (35), or were non-medical (8). Of the 440
(25.2%) responses included, 263 (25.1%) were palliative
medicine doctors and 177 (25.2%) participants were re-
spiratory doctors (Table 1). Results from Australia and
New Zealand were combined, given the smaller work-
force and thus limited number of participants from New
Zealand (21 palliative medicine specialists and 25 re-
spiratory physicians).
The majority of respiratory doctors (140, 80.9%) re-
ported being very or quite comfortable providing a pal-
liative approach to people with COPD. Only eight (4.6%)
respiratory participants were quite or very uncomfort-
able offering this care, and the remainder were neutral.
Respiratory doctors’ demographic characteristics and ex-
perience (including age, gender, country, specialty, pos-
ition and location of practice, mean years worked in
specialty and mean number of patients with severe
COPD seen per month) were not associated with level of
comfort providing a palliative approach.
Almost two thirds of respiratory doctors (113, 63.8%)
recommended referring the person in the case vignette
to specialist palliative care, with 90 (50.8%) recommend-
ing referring for long-term specialist palliative care input
and 23 (13.0%) for an opinion only. Thirteen (7.3%) par-
ticipants were uncertain if they would refer and the re-
mainder would not. Female respiratory doctors were
twice as likely as their male colleagues to recommend
referral to the specialist palliative care service (OR = 2.0,
95%CI = 1.0–3.9, p = 0.048). No other demographic char-
acteristics or experience were associated with respiratory
doctors recommending referral to specialist palliative
care.
Respiratory doctors referred people with COPD for
many reasons including for: psychosocial and spiritual
care (105, 59.3%), carer support including future be-
reavement support (104, 58.5%), and end-of-life care (94,
53.1%) (Table 2). Of the 64 (36.2%) respiratory physi-
cians who would not or were unsure if they would refer
to specialist palliative care, 27 (15.3%) reported being
able to provide a palliative approach themselves, 19
(10.7%) reported difficulty accessing palliative care in
their location and 13 (7.3%) thought the person de-
scribed in the case vignette was unlikely to die within
the next 12 months.
Nearly all doctors working in both respiratory (172,
97.2%) and palliative medicine (260, 98.9%) reported that
they would initiate a discussion with the person in the
case vignette (or similar people) regarding prognosis and
advance care planning. Only 4 doctors (all respiratory)
reported that they would not initiate this discussion with
the person in the case vignette (or similar patients), with
2 reporting lack of time as a barrier. Holding the belief
that advance care planning should be undertaken was
not associated with any of the participants’ demographic
characteristics or experience for each specialty.
Both specialist groups recommended discussing mul-
tiple topics during ACP conversations including: mech-
anical ventilation and/or intensive care unit admission in
the future, the utility of cardiopulmonary resuscitation,
and the nature and role of palliative care (Table 3).
Table 1 Participant demographics
Palliative Medicine (n = 263) Respiratory Medicine Specialties Compared
ANZ (n = 129) UK (n = 134) All (n = 263) ANZ (n = 177)
Female 80 (62.0%) 112 (83.6%) 192 (73.0%) 61 (34.4%) p < 0.0001
Age
25–35 25 (19.3%) 31 (23.1%) 56 (21.3%) 40 (22.6%) p = 0.953
36–45 27 (20.9%) 50 (37.3%) 77 (29.3%) 57 (32.2%)
46–55 31 (24.0%) 36 (26.9%) 67 (25.5%) 39 (22.0%)
56–65 29 (22.5%) 15 (11.2%) 44 (16.7%) 27 (15.3%)
> 65 11 (8.5%) 0 11 (4.2%) 8 (4.5%)
Missing 6 (4.7%) 2 (1.5) 8 (3.0%) 6 (3.4%)
Position
Consultant 89 (69.0%) 107 (79.9%) 196 (74.5%) 145 (81.9%) p = 0.068
Specialist trainee 40 (31.0%) 27 (20.1%) 67 (25.5%) 32 (18.1%)
Mean years in specialty a 12.5 (9.1) 12.3 (7.3) 12.4 (8.2) 15.0 (10.8) p = 0.006
Mean no. of COPD patients seen/month a 3.1 (3.1) 2.5 (3.4) 2.8 (3.3) 14.1 (12.0) p < 0.0001
Data are represented as either frequencies or means (denoted by a), with either proportions or standard deviations in parentheses
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Palliative medicine doctors were significantly more likely
to recommend discussing: what palliative care is and
whether indicated (p < 0.0001), what death and dying
might be like from COPD (p < 0.0001), the likely prog-
nosis (p = 0.004) and changing treatment goals to aim
for palliation (p = 0.028).
Many themes were identified in the extensive free
text comments participants wrote, including that spe-
cialists believed current palliative care arrangements
for people with advanced COPD are inadequate and
fragmented:
“(This is a) difficult and big problem, and an area
that clearly requires greater investment into formal
palliative care services for this patient group, and
greater formal systems of collaboration between
respiratory physicians, palliative care teams, and
community health providers.” [Respiratory Medicine
Specialist number 13, ANZ]
Fear of palliative care by both clinicians and patients
was also noted as an issue:
“Of our palliative care patients I think they have the
greatest number of unmet needs, but often they or their
clinicians are fearful of what palliative care entails.”
[Palliative Medicine Specialist number 39, ANZ]
There was also concern that both people with COPD
and their caregivers experience issues such as anxiety:
“COPD is hard to palliate. Patients find the
exacerbations distressing and panic inducing. This
also contributes to carer anxiety.” [Palliative Medicine
Specialist number 62, UK]
Additionally, limited available support from palliative
care services currently was highlighted as an issue.
“Unfortunately our local palliative care service is
under-resourced to support similar patients to this due
to the frequent longevity of their needs. This is likely to
be a growing problem in the future.” [Respiratory
Medicine Specialist number 71, ANZ]
Finally, both respiratory and palliative medicine physi-
cians raised concerns regarding each other’s knowledge
and practices.
“Palliative care physicians manage this (COPD
patients) very poorly.” [Respiratory Medicine Specialist
number 4, ANZ]
“It’s end organ disease - we need to enable respiratory
physicians to manage their patients in all phases of
the illness, and use consultative services when
necessary, rather than ‘handing over’ care to palliative
care when goals of care are palliative.” [Palliative
Medicine Specialist number 57, UK]
Discussion
Recent international surveys of respiratory doctors have
examined referral practices to specialist palliative care in
the context of organisation of current service models,
availability and local health policies [21, 30, 31]. In this
large, multi-national study spanning three countries, in
addition to examining recognised barriers to referring to
specialist palliative care, we also uniquely identified that
the majority of respiratory doctors are comfortable pro-
viding a palliative approach, but also recognise the role
of specialist palliative care for people with advanced
COPD. Additionally, both respiratory and palliative
Table 2 Respiratory doctors’ referrals to specialist palliative care
Reasons for referring COPD patients to palliative care N = 113a
For holistic care including psychosocial and
spiritual care
105 (59.3%)
For carer support including future bereavement
support
104 (58.8%)
For future end-of-life care 94 (53.1%)
To access community palliative care 92 (52.0%)
To access respite care 78 (44.1%)
For management of symptoms including
breathlessness
75 (42.4%)
For completion of advance care planning 63 (36.2%)
Reasons for not referring COPD patients to
palliative care
N = 64b
I am capable of providing generalist palliative
care myself
27 (15.3%)
Palliative care services are difficult to access
in my location
19 (10.7%)
I do not think the patient might die in
the next 12 months
13 (7.3%)
I do not want the patient to feel abandoned
by me
7 (4.0%)
The patient does not require specialist palliative
care yet
6 (3.4%)
I do not want to take away the patient’s hope 4 (2.3%)
Previously have not found palliative care
teams helpful for COPD patients
3 (1.7%)
Data are represented as frequencies with proportions of the total group (n =
177) in parentheses
aOnly participants who said they would refer to palliative care were directed
to answer this question
b Only participants who said they would NOT/were unsure regarding referral
to palliative care were directed to answer
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medicine doctors acknowledge the importance of ACP
discussions and identify similar key topics to discuss.
However, current working models are considered inad-
equate with insufficient communication and collabor-
ation between the many health professionals often
involved in caring for people with advanced COPD.
Attitudes to palliative care
The vast majority of respiratory doctors from Australia
and New Zealand, including doctors in specialist train-
ing, reported being very or quite comfortable providing
a palliative approach to people with COPD. This finding
is novel and may partly explain why people with COPD
are infrequently referred to specialist palliative care ser-
vices in Australia [15, 17]. Interestingly few participants
in this study reported poor access to specialist palliative
care services as an obstacle to referring COPD patients.
By contrast respiratory physicians in the UK, Netherlands,
and Sweden have cited lack of access to specialist palliative
care services as an important barrier for people with
COPD [32]. Instead, in this study participants highlighted
that whilst specialist palliative care services were available,
these services did not have the capacity or experience to
manage advanced COPD patients, and importantly estab-
lished relationships between respiratory and palliative
medicine were absent.
Senior doctors’ attitudes to specialist palliative care
have been described as a barrier to referring people with
cancer to these services [33]. However, the majority of
respiratory doctors in our study recognised the benefits
of referring people with advanced COPD to specialist
palliative care. However, some respiratory doctors fo-
cussed on the prognosis and limited survival, as opposed
to patients’ needs when considering referral to specialist
palliative care. Notably female doctors were considerably
more likely to recommend referral to specialist palliative
care. Likewise, when Australian junior doctors within
their first five years of qualifying were surveyed (using
this same questionnaire) regarding their knowledge and
experiences managing people with advanced COPD, fe-
male trainees were approximately three times more
likely to suggest referring to palliative care than male
trainees [34]. This consistent finding requires further in-
vestigation to understand the reasons behind this differ-
ence in female doctors’ reported practices.
The principle reasons for referring to specialist pallia-
tive care in this survey were for access to psychosocial
and spiritual care, carer support including bereavement
support, and end-of-life care. A survey of British respira-
tory physicians also identified that the main reasons for
seeking specialist palliative care for people with chronic
lung diseases were for end-of-life care (63%) and psycho-
logical support (70%) [21]. Likewise, Australian junior
Table 3 Recommended ACP discussion topics
Resp Med Pall Med
ACP topics
The utility of CPR in the future 159 (89.8%) 249 (94.7%)
Mechanical ventilation and/or ICU admission in the future 164 (92.7%) 241 (91.6%)
What palliative care is and if this is indicated 139 (78.5%) 246 (93.5%)
What death and dying might be like from COPD 97 (54.8%) 200 (76.0%)
The likely prognosis in months and years 100 (56.5%) 191 (72.6%)
Changing treatment goals to be palliative 111 (62.7%) 191 (72.6%)
Appointing a medical power of attorney or substitute decision maker 123 (69.5%) 185 (70.3%)
Other treatment limitations 4 (2.3%) 20 (7.6%)
Other suggested topics
Desired place of future care (home/hospital/hospice) 0 39 (14.8%)
Desired place of death 0 37 (14.1%)
The patient’s goals, values, wishes, hopes & fears 2 (1.1%) 27 (10.3%)
Ascertain the patient’s understanding and knowledge first 3 (1.7%) 4 (1.5%)
Patient led discussion 0 22 (8.4%)
Future wishes regarding antibiotics 3 (1.7%) 10 (3.8%)
Future wishes regarding NIV 3 (1.7%) 9 (3.4%)
Advance treatment directives 0 12 (4.6%)
Making a will or arranging affairs 1 (0.6% 7 (2.7%)
Data are represented as frequencies with proportions of the total group (n = 177) in parentheses
CPR Cardiopulmonary resuscitation, ICU Intensive Care Unit, NIV Non-invasive ventilation
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doctors reported referring people with COPD to special-
ist palliative care to access community palliative care in-
put (54%) and end-of-life care (45%) [34]. However, in
the current study, respiratory doctors less commonly
recommended referral for symptom management (42%),
compared to 63% of British respiratory physicians and
62% of Australian junior doctors who referred for this
reason [21, 34]. This would suggest that the ANZ re-
spiratory doctors surveyed in this study not only feel
comfortable providing a palliative approach, but also
have greater confidence in managing difficult symptoms
such as chronic breathlessness. However, there remains
a significant need for specialist palliative care for people
with COPD, particularly for psychosocial and existential
support, addressing communication needs and for be-
reavement support of carers [11].
Advance care planning
The significant need for good communication and ACP
in people with COPD and their carers is well-described
[35, 36], and in this study was almost universally recog-
nised. The responsibility for ACP rests with respiratory
doctors as suggested by the majority of respondents in
this study. Notably, while both specialties suggested
similar topics should be covered within ACP and that it
may involve several discussions, palliative medicine doc-
tors were more likely to address challenging topics such as
death and dying, prognosis, treatment limitations and
place of future care as part of these discussions. Similarly,
palliative medicine doctors recommended patient-led
ACP discussions. Both specialties therefore report being
engaged with ACP and their different approaches and
skills appear to be complementary over the series of ACP
conversations a patient may require. Therefore ideally re-
spiratory doctors should initiate these discussions, and
palliative medicine doctors can then develop and expand
the conversation as the illness progresses and according to
each person’s needs and wishes.
Models of care
Confidence providing a palliative approach, managing
difficult symptoms such as chronic breathlessness and
awareness regarding the importance of ACP in people
with advanced COPD does not necessarily translate into
practice. A number of authors have documented the sig-
nificant unmet palliative care needs reported by COPD
patients [35] and the infrequent engagement in ACP dis-
cussions [21, 22, 25, 35, 37], suggesting a mismatch be-
tween our participants’ responses and actual day-to-day
clinical practice. Therefore it is not lack of awareness or
confidence that is preventing clinicians from addressing
the significant needs of people with advanced COPD.
While lack of time may be a barrier, participants in this
study raised concerns regarding the educational needs of
doctors in each specialty and highlighted that current
models of care are fragmented, with little collaboration
between respiratory medicine, palliative medicine or pri-
mary care. Accessible, integrated, multi-disciplinary ser-
vices, which embrace collaboration, trust and bi-directional
education and support between both respiratory medicine
and palliative care may overcome some of these issues [38].
Such integrated services include the Melbourne Advanced
Lung Disease Service [39], and the London Breathlessness
Support Service [40], both of which have demonstrated im-
proved outcomes for people with COPD. However, larger,
multi-site trials are required to fully assess these new
models of care.
This study has some limitations. We had intended to
survey British respiratory physicians, however, the Brit-
ish Thoracic Society declines to disseminate research
surveys to its members. The response rate in this study,
whilst similar to other online surveys of physicians [41–
43], was low, thus limiting the generalisability of our
findings. However, the gender and age characteristics of
participants in this study were representative of the
workforce demographics in all three countries [14, 17,
44–46]. Additionally, surveys require respondents to
make black and white decisions to hypothetical scenar-
ios, whereas in clinical practice these issues are not ab-
solutely clear, instead requiring careful consideration.
Conclusions
Both respiratory and palliative medicine doctors recog-
nised the significant palliative care and ACP needs of
people with advanced COPD. Respiratory doctors re-
ported being comfortable providing a palliative approach
and acknowledged the role of both specialist palliative
care and ACP, yet in reality people with advanced COPD
rarely access these elements of care. Additionally,
current models of care for people with COPD were con-
sidered inadequate and fragmented. Collaboration, trust,
and bi-directional education between respiratory and
palliative medicine, perhaps through integrated, multi-
disciplinary services, are urgently required to address the
unmet needs of people with advanced COPD.
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